Clinical Trials Logo

Filter by:
NCT ID: NCT05673915 Recruiting - Focal Epilepsy Clinical Trials

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

Start date: April 12, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.

NCT ID: NCT05682144 Recruiting - Clinical trials for Mucopolysaccharidosis IS

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Start date: April 12, 2023
Phase: Phase 1
Study type: Interventional

A first-in-human study using ISP-001 in adult patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.

NCT ID: NCT05685173 Recruiting - Clinical trials for B-cell Non-Hodgkins Lymphoma (B-NHL)

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Participants With Aggressive B-cell Non-Hodgkin Lymphomas

ATHENA-1
Start date: April 12, 2023
Phase: Phase 1
Study type: Interventional

The study is researching an experimental drug called REGN5837 in combination with another experimental drug, odronextamab. The aim of the study is to see how safe and tolerable the study drugs are, and to define the recommended dose for phase 2 for the combination. The study is focused on patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphomas (B-NHLs). The study is looking at several other research questions, including: - What side effects may happen from taking the study drugs - How much study drug is in your blood at different times - Whether the body makes antibodies against the study drugs (that could make the drugs less effective or could lead to side effects) - To find out how well the study drugs work against relapsed or refractory aggressive B-cell non-Hodgkin lymphomas (B-NHLs)

NCT ID: NCT05691647 Recruiting - Depressive Episode Clinical Trials

Chronotherapy for Depressive Episodes

Start date: April 12, 2023
Phase: N/A
Study type: Interventional

Evidence-based treatments for depression, such as antidepressive medication, usually have a latency of 4 to 6 weeks before they achieve a therapeutic effect. Chronotherapy is a group of non-pharmacological interventions that presumably act on the circadian system to achieve a rapid-onset clinical effect and better long-term effects and has been shown efficient to improve depressive symptoms. Interventions include sleep deprivation, sleep-phase advancement and stabilization, and light therapy. There are few studies testing the effectiveness of combining these three chronotherapeutic techniques in the initial phase of treatment of depression in a secondary mental health care outpatient clinic. The investigators aim to test the effects and safety of chronotherapy in addition to TAU compared to TAU alone, with the primary outcome being self-reported depressive symptoms at 1 week following randomization. The study is a randomized controlled trial with 76 patients with a depressive episode who initiate outpatient treatment at Nidaros DPS, St. Olavs University Hospital. Participants will be allocated 1:1 to either chronotherapy + treatment as usual (TAU) or to TAU alone.

NCT ID: NCT05696288 Recruiting - Clinical trials for Head and Neck Cancer

Conventional Oxygen Therapy Versus Continuous Transnasal High Flow Oxygen Therapy for Head and Neck Diagnostic Panendoscopy Under General Anesthesia in Spontaneous Ventilation

OPTINOSE
Start date: April 12, 2023
Phase: N/A
Study type: Interventional

The high-flow oxygen therapy system, also called the THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) system, appears to provide better patient safety than conventional techniques. Panendoscopy is a very common diagnostic procedure in ENT surgery. The general anesthesia during the diagnostic panendoscopy is a good representation of the induction stage. Indeed, the procedure of preoxygenation preceding anesthetic induction and direct laryngoscopy corresponds to the airway management that is an integral part of each general anesthesia. This is why researchers are studying it in particular to improve patient safety during difficult intubations. The paradox is that there is no consensus on the anesthetic strategy for this procedure that counts four main methods for the airway management of patients requiring an ENT panendoscopy. In our center, the investigators use, in most situations, a variant of spontaneous ventilation described by Y. Jacquet et al., with the difference that the investigators use a transglottic oxygenation probe during the procedure. During laryngoscopy, the operator positions a naso-tracheal tube after local anesthesia of the vocal cords. The oxygen flow is reduced to 3 L/min before the exploration procedure. The arrival in operating theaters of the Optiflowâ„¢ system, developed by the New Zealand Company Fisher & Paykel Healthcare, has led to a rethinking of the way oxygen is delivered. This device allows the administration of a flow rate of up to 70 L/min while delivering heated gases.

NCT ID: NCT05724836 Recruiting - Clinical trials for Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque

Prospective Carotid Artery Stenosis Trial

Start date: April 12, 2023
Phase:
Study type: Observational [Patient Registry]

Researchers are collecting information and blood from subjects undergoing carotid artery interventions.

NCT ID: NCT05730933 Recruiting - Clinical trials for Eosinophilic Esophagitis

An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.

Start date: April 12, 2023
Phase: N/A
Study type: Interventional

In many chronic conditions adherence to long-term treatment is a challenge, also for patients with eosinophilic esophagitis. Interventions, such as behavioral, educational and reminder interventions might improve treatment adherence. With this trial the investigators want to assess the effects of additional education in combination with more frequent follow up and patient reminders on adherence to treatment in adult patients with eosinophilic esophagitis.

NCT ID: NCT05743283 Recruiting - Wound Heal Clinical Trials

Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds

Start date: April 12, 2023
Phase: N/A
Study type: Interventional

The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete brief surveys about their healing and well-being related to the wound healing.

NCT ID: NCT05748873 Recruiting - Clinical trials for Retinitis Pigmentosa

Promising ROd-cone DYstrophy Gene therapY

PRODYGY
Start date: April 12, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a two-step, multicenter, Phase I/II study including an open-label dose-escalation phase (Step 1) and a three-arm controlled double-masked randomized extension phase (Step 2), in subjects with advanced RCD due to a mutation in the RHO, PDE6A, or PDE6B gene.

NCT ID: NCT05752461 Recruiting - Clinical trials for Prevention of Venous Thromboembolism After Knee Arthroplasty

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Start date: April 12, 2023
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty